These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29522253)

  • 61. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.
    Elgart A; Zur AA; Mimrod D; Dror V; Bar-Ilan O; Korver T; Spiegelstein O
    Eur J Clin Pharmacol; 2019 Jan; 75(1):41-49. PubMed ID: 30191262
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.
    Saperstein S; Edgren RA; Lee GJ; Jung D; Fratis A; Kushinsky S; Mroszczak E; Dorr A
    Contraception; 1989 Nov; 40(5):581-90. PubMed ID: 2612166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF; Timmer CJ; Lammers P
    Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ethinylestradiol from contraceptive formulations and the ovarian response: an estrogen dose-dependency on natural estradiol concentrations.
    Sojo-Aranda I; Cortés-Gallegos V
    Gynecol Endocrinol; 1995 Mar; 9(1):63-6. PubMed ID: 7793302
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
    Doose DR; Wang SS; Padmanabhan M; Schwabe S; Jacobs D; Bialer M
    Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
    Kuhnz W; Blode H; Mahler M
    Contraception; 1994 Mar; 49(3):255-63. PubMed ID: 8200219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
    Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
    Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.
    Boyd RA; Zegarac EA; Posvar EL; Flack MR
    Contraception; 2001 Feb; 63(2):71-6. PubMed ID: 11292470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
    Menon S; Riese R; Wang R; Alvey CW; Shi H; Petit W; Krishnaswami S
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):336-42. PubMed ID: 27138968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, double-blind study of six combined oral contraceptives.
    Contraception; 1982 Mar; 25(3):231-41. PubMed ID: 6804161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
    Souka AR; Kamel M; Einen MA; Saleh F; Sallam H
    Contraception; 1985 Jun; 31(6):571-81. PubMed ID: 3899504
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
    Stanczyk FZ; Lobo RA; Chiang ST; Woutersz TB
    Contraception; 1990 Jan; 41(1):39-53. PubMed ID: 2105872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.